Impact of Race, Age, and Socioeconomic Status on Participation in Pancreatic Cancer Clinical Trials

Objectives:Over 18 years, 7 phase 2 trials in advanced pancreatic cancer (APC) were conducted at Karmanos Cancer Institute (KCI). We sought factors that influenced the selection of patients for clinical trials and explored differences in overall survival (OS) of patients treated on clinical trials v